105 related articles for article (PubMed ID: 17118339)
1. Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.
Yong SL; Ni Y; Zhang T; Tester DJ; Ackerman MJ; Wang QK
Biochem Biophys Res Commun; 2007 Jan; 352(2):378-83. PubMed ID: 17118339
[TBL] [Abstract][Full Text] [Related]
2. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Potet F; Beckermann TM; Kunic JD; George AL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
[TBL] [Abstract][Full Text] [Related]
3. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes.
Vecchietti S; Grandi E; Severi S; Rivolta I; Napolitano C; Priori SG; Cavalcanti S
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H56-65. PubMed ID: 16980337
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
[TBL] [Abstract][Full Text] [Related]
5. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
Zhang T; Yong SL; Drinko JK; Popović ZB; Shryock JC; Belardinelli L; Wang QK
Int J Cardiol; 2011 Mar; 147(2):239-45. PubMed ID: 19762097
[TBL] [Abstract][Full Text] [Related]
6. Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials.
Grandi E; Puglisi JL; Wagner S; Maier LS; Severi S; Bers DM
Biophys J; 2007 Dec; 93(11):3835-47. PubMed ID: 17704163
[TBL] [Abstract][Full Text] [Related]
7. Enhanced late sodium current underlies pro-arrhythmic intracellular sodium and calcium dysregulation in murine sodium channelopathy.
Rivaud MR; Baartscheer A; Verkerk AO; Beekman L; Rajamani S; Belardinelli L; Bezzina CR; Remme CA
Int J Cardiol; 2018 Jul; 263():54-62. PubMed ID: 29754923
[TBL] [Abstract][Full Text] [Related]
8. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
9. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model.
Hund TJ; Rudy Y
Circulation; 2004 Nov; 110(20):3168-74. PubMed ID: 15505083
[TBL] [Abstract][Full Text] [Related]
10. A transgenic zebrafish model of a human cardiac sodium channel mutation exhibits bradycardia, conduction-system abnormalities and early death.
Huttner IG; Trivedi G; Jacoby A; Mann SA; Vandenberg JI; Fatkin D
J Mol Cell Cardiol; 2013 Aug; 61():123-32. PubMed ID: 23791817
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
Hothi SS; Booth SW; Sabir IN; Killeen MJ; Simpson F; Zhang Y; Grace AA; Huang CL
Prog Biophys Mol Biol; 2008; 98(2-3):267-80. PubMed ID: 19351517
[TBL] [Abstract][Full Text] [Related]
12. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
Clancy CE; Tateyama M; Kass RS
J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
[TBL] [Abstract][Full Text] [Related]
13. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels.
Wagner S; Dybkova N; Rasenack EC; Jacobshagen C; Fabritz L; Kirchhof P; Maier SK; Zhang T; Hasenfuss G; Brown JH; Bers DM; Maier LS
J Clin Invest; 2006 Dec; 116(12):3127-38. PubMed ID: 17124532
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
15. Changes in action potentials and intracellular ionic homeostasis in a ventricular cell model related to a persistent sodium current in SCN5A mutations underlying LQT3.
Christé G; Chahine M; Chevalier P; Pásek M
Prog Biophys Mol Biol; 2008; 96(1-3):281-93. PubMed ID: 17892895
[TBL] [Abstract][Full Text] [Related]
16. Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium.
Stocker PJ; Bennett ES
J Gen Physiol; 2006 Mar; 127(3):253-65. PubMed ID: 16476705
[TBL] [Abstract][Full Text] [Related]
17. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
[TBL] [Abstract][Full Text] [Related]
18. Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Tian XL; Cheng Y; Zhang T; Liao ML; Yong SL; Wang QK
Biochem Biophys Res Commun; 2007 Jan; 352(4):879-83. PubMed ID: 17157817
[TBL] [Abstract][Full Text] [Related]
19. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
20. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.
Papadatos GA; Wallerstein PM; Head CE; Ratcliff R; Brady PA; Benndorf K; Saumarez RC; Trezise AE; Huang CL; Vandenberg JI; Colledge WH; Grace AA
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6210-5. PubMed ID: 11972032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
